Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Denise J. Stommel-Jenner"'
Autor:
Anja Tüchler, Antoine De Pauw, Corinna Ernst, Amélie Anota, Inge M.M. Lakeman, Julia Dick, Nienke van der Stoep, Christi J. van Asperen, Monika Maringa, Natalie Herold, Britta Blümcke, Robert Remy, Anke Westerhoff, Denise J. Stommel-Jenner, Eléonore Frouin, Lisa Richters, Lisa Golmard, Nadine Kütting, Chrystelle Colas, Barbara Wappenschmidt, Kerstin Rhiem, Peter Devilee, Dominique Stoppa-Lyonnet, Rita K. Schmutzler, Eric Hahnen
Publikováno v:
Breast, Vol 73, Iss , Pp 103615- (2024)
Background: Breast cancer (BC) risk prediction models consider cancer family history (FH) and germline pathogenic variants (PVs) in risk genes. It remains elusive to what extent complementation with polygenic risk score (PRS) and non-genetic risk fac
Externí odkaz:
https://doaj.org/article/f91dd96772b24b38a3d25235b52f3750
Autor:
Delal Akdeniz, Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Ewout W. Steyerberg, Michael Hauptmann, Irma van de Beek, Klaartje van Engelen, Marijke R. Wevers, Encarnacion B. Gómez García, Margreet G.E.M. Ausems, Lieke P.V. Berger, Christi J. van Asperen, Muriel A. Adank, Margriet J. Collée, Denise J. Stommel-Jenner, Agnes Jager, Marjanka K. Schmidt, Maartje J. Hooning
Publikováno v:
Breast, Vol 61, Iss , Pp 98-107 (2022)
Aim: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral breast cancer (CBC). In a nationwide cohort, we investigated the effects of chemotherapeutic agents given for PBC on CBC risk separately in BRCA1 and BR
Externí odkaz:
https://doaj.org/article/f07b5cdd82d14cf6b8c51743fa5578cb
Autor:
Rosa de Groot, Antoinette Hollestelle, Klaartje van Engelen, Muriel A Adank, Marjanka K Schmidt, Marinus J Blok, Frans B L Hogervorst, Johan J P Gille, Lieke P V Berger, Marijke R Wevers, Maartje A.C. Schreurs, Denise J Stommel-Jenner, Christi J. Van Asperen, Margreet G.E.M. Ausems, Willemina Geurts-Giele, Maartje J. Hooning
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Purpose CHEK2 c.1100delC is associated with an increased breast cancer risk in women. While this variant is prevalent in the Netherlands (1% in the general population), knowledge of aetiology and prognosis of breast cancer and other tumours in CHEK2
Externí odkaz:
https://doaj.org/article/12b3376b0c36448f8b0fb3ed4b761bd3